Flu Vaccine Makers on Watch as U.S. Reaches Epidemic Level (GSK) (NVS) (SNY)
Tweet
Share
E-mailGet Alerts GSK Hot Sheet
Join SI Premium – FREE
The Centers for Disease Control and Prevention (CDC) announced today that influenza-related deaths in the U.S. are at epidemic levels. Epidemic would be when incidence is above "expected" levels, while pandemic is an epidemic of an infectious disease that spreads through human populations across a large region, like a continent.
The U.S. is not at the pandemic level.
On watch are flu vaccine makers. The one's listed by the CDC include:
Given the size of thses companies, its unlikely that a heavy flu season will move the needle too much. But, traders will still be keeping an eye as more developments surface.
All three are lower on Friday's session.
The U.S. is not at the pandemic level.
On watch are flu vaccine makers. The one's listed by the CDC include:
- GlaxoSmithKline (NYSE: GSK) - Fluarix;
- Sanofi Pasteur (NYSE: SNY) - Fluzone; and
- Novartis (NYSE: NVS) - Fluvirin, Agriflu.
Given the size of thses companies, its unlikely that a heavy flu season will move the needle too much. But, traders will still be keeping an eye as more developments surface.
All three are lower on Friday's session.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
- Sunshine Biopharma gets Canadian approval for generic Enalapril
- Pliant Therapeutics gets FDA Fast Track for PLN-101095 in solid tumors
Create E-mail Alert Related Categories
FDA, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
